Beta Bionics Inc.
XNAS:BBNX
| Market Cap (Intraday) | 647.48M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $11.42 |
| 50-Day MA | $10.71 |
| 200-Day MA | $18.67 |
Beta Bionics Inc. Stock, XNAS:BBNX
11 Hughes, Irvine, California 92618
United States of America
Phone: +1.949.427.7785
Number of Employees: 277
Description
Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.